Abnormal striatal dopamine transmission in schizophrenia

Curr Med Chem. 2013;20(3):397-404. doi: 10.2174/0929867311320030011.


Despite numerous revisions and reformulations, dopamine (DA) hypothesis of schizophrenia remains a pivotal neurochemical hypothesis of this illness. The aim of this review is to expose and discuss findings from positron emission tomography (PET) or single-photon- emission computed tomography (SPECT) studies investigating DA function in the striatum of medicated, drug-naive or drug-free patients with schizophrenia and in individuals at risk compared with healthy volunteers. DA function was studied at several levels: i) at a presynaptic level where neuroimaging studies investigating DOPA uptake capacity clearly show an increase of DA synthesis in patients with schizophrenia; ii) at a synaptic level where neuroimaging studies investigating dopamine transporter availability (DAT) does not bring any evidence of dysfunction; iii) and finally, neuroimaging studies investigating DA receptor density show a mild increase of D2 receptor density in basic condition and, an hyperreactivity of DA system in dynamic condition. These results are discussed regarding laterality, sub-regions of striatum and implications for the at-risk population. Striatal DA abnormalities are now clearly demonstrated in patients with schizophrenia and at risk population and could constitute an endophenotype of schizophrenia. Subtle sub-clinical striatal DA abnormalities in at risk population could be a biomarker of transition from a vulnerability state to the expression of frank psychosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Dopamine / metabolism*
  • Humans
  • Neostriatum / metabolism
  • Neostriatum / physiopathology*
  • Positron-Emission Tomography
  • Schizophrenia / metabolism
  • Schizophrenia / physiopathology*
  • Synaptic Transmission*
  • Tomography, Emission-Computed, Single-Photon


  • Dopamine